ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

NIPPON INDIA PHARMA FUND

NIPPON Nippon India Mutual Fund Feb 2022 — Sep 2026 55 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹8,919 CrAt NSE closes, Sep 2026
Companies held3636 with an NSE price
Top 10 holdings57.9%Of the equity shown here
Largest holding12.0%Sun Pharmaceutical Industries Limited
12-month turnover15.0%Estimated from 12 monthly disclosures · compare

Days to sell half: 22.8 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Takes days, not hours, to unwind. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

55 priced months, Feb 2022 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

57.9% now, 58.4% in Sep 2025 · highest 74.1%, lowest 56.7%

Companies held

36 now, 37 in Sep 2025 · largest single holding 12.0% of equity

How long new positions last: of the 16 companies this fund started holding between Mar 2022 and Jul 2025, 81% were still held a year later — it usually keeps what it buys. Across active funds the figure is about 50%, and a fund’s figure has stayed similar from year to year. A description of how the fund is run, not of its results. How this was tested →

How it trades: leans toward adding to shares that fell over the previous six months (score -0.56 over 7 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUNDAditya Birla Sun Life · 28 shared65.3%
  2. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 26 shared61.9%
  3. Motilal Oswal BSE Healthcare ETFMotilal Oswal · 34 shared60.4%
  4. Bandhan BSE Healthcare Index FundBandhan · 34 shared60.4%
  5. EODWHFEdelweiss · 18 shared60.2%
  6. Bandhan Healthcare FundBandhan · 20 shared57.6%
  7. DSP Nifty Healthcare ETFDSP · 15 shared57.2%
  8. DSP Nifty Healthcare Index FundDSP · 15 shared57.2%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 0 Companies added
Complete exits 0 Companies sold out
Increases 1 More shares than last month
Reductions 2 Fewer shares than last month

New positions

CompanyShares
  1. None this month.

Complete exits

CompanyShares
  1. None this month.

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 12.03% 1,073 Cr 0.59 Cr by Feb 2022 (55 mo+)
Divi's Laboratories Limited Healthcare Large Cap 7.30% 651 Cr 0.07 Cr by Feb 2022 (55 mo+)
Lupin Limited Healthcare Mid Cap 6.34% 565 Cr 0.28 Cr by Feb 2022 (55 mo+)
Cipla Limited Healthcare Large Cap 6.18% 551 Cr 0.41 Cr by Feb 2022 (55 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 5.60% 499 Cr 0.40 Cr by Feb 2022 (55 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 5.02% 448 Cr 0.05 Cr by Feb 2022 (55 mo+)
Mankind Pharma Limited Healthcare Mid Cap 4.50% 401 Cr 0.16 Cr Apr 2023 (41 mo)
Sai Life Sciences Limited Healthcare Small Cap 4.03% 359 Cr 0.24 Cr Dec 2024 (22 mo)
Ajanta Pharma Limited Healthcare Small Cap 3.71% 331 Cr 0.09 Cr Apr 2022 (53 mo)
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 3.20% 285 Cr 0.10 Cr Aug 2022 (49 mo)
IPCA Laboratories Limited Healthcare Mid Cap 2.95% 263 Cr 0.14 Cr Nov 2024 (23 mo)
Max Healthcare Institute Limited Healthcare Large Cap 2.77% 247 Cr 0.27 Cr Oct 2025 (12 mo)
Vijaya Diagnostic Centre Limited Healthcare Small Cap 2.69% 240 Cr 0.17 Cr by Feb 2022 (55 mo+)
Medplus Health Services Limited Consumer Services Small Cap 2.60% 232 Cr 0.35 Cr Nov 2022 (46 mo)
Gland Pharma Limited Healthcare Small Cap 2.60% 232 Cr 0.08 Cr by Feb 2022 (55 mo+)
Abbott India Limited Healthcare Mid Cap 2.39% 213 Cr 78,546 by Feb 2022 (55 mo+)
Piramal Pharma Limited Healthcare Small Cap 2.30% 205 Cr 0.99 Cr Jun 2026 (4 mo)
Thyrocare Technologies Limited Healthcare Small Cap 2.30% 205 Cr 0.38 Cr by Feb 2022 (55 mo+)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 2.23% 199 Cr 0.10 Cr Jun 2024 (28 mo)
Alkem Laboratories Limited Healthcare Mid Cap 1.87% 167 Cr 0.03 Cr by Feb 2022 (55 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 1.69% 151 Cr 0.09 Cr by Feb 2022 (55 mo+)
Narayana Hrudayalaya Ltd. Healthcare Mid Cap 1.65% 148 Cr 0.08 Cr by Feb 2022 (55 mo+)
Suraksha Diagnostic Limited Not classified Small Cap 1.55% 138 Cr 0.39 Cr Nov 2024 (23 mo)
Syngene International Limited Healthcare Small Cap 1.43% 128 Cr 0.35 Cr Oct 2022 (47 mo)
Emcure Pharmaceuticals Limited Healthcare Small Cap 1.40% 125 Cr 0.06 Cr Jul 2024 (27 mo)
Pfizer Limited Healthcare Small Cap 1.38% 123 Cr 0.03 Cr by Feb 2022 (55 mo+)
Akums Drugs and Pharmaceuticals Limited Healthcare Small Cap 1.24% 111 Cr 0.14 Cr Apr 2025 (18 mo)
Anthem Biosciences Limited Healthcare Mid Cap 1.23% 109 Cr 0.13 Cr Jul 2025 (15 mo)
Fortis Healthcare Limited Healthcare Mid Cap 1.16% 104 Cr 0.13 Cr by Feb 2022 (55 mo+)
Biocon Limited Healthcare Mid Cap 1.04% 92.73 Cr 0.25 Cr Jan 2025 (21 mo)
Sanofi India Limited Not classified Small Cap 1.03% 91.79 Cr 0.03 Cr by Feb 2022 (55 mo+)
Sanofi Consumer Healthcare India Limited Not classified Small Cap 0.91% 81.25 Cr 0.02 Cr Jun 2024 (28 mo)
Molbio Diagnostics Limited Not classified — 0.56% 49.78 Cr 0.04 Cr Aug 2026 (2 mo)
Indoco Remedies Limited Not classified Small Cap 0.49% 43.96 Cr 0.17 Cr by Feb 2022 (55 mo+)
AstraZeneca Pharma India Limited Not classified Small Cap 0.43% 38.70 Cr 62,568 Dec 2023 (33 mo)
Concord Biotech Limited Healthcare Small Cap 0.17% 15.35 Cr 0.01 Cr Aug 2023 (37 mo)

Half of its current holdings have been held for 49 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Sai Life Sciences Limited Sep 2026 ▼ Reducing -0.02 Cr
Indoco Remedies Limited Sep 2026 ▼ Reducing -0.02 Cr
Abbott India Limited Sep 2026 ▲ Increasing +420
Biocon Limited Aug 2026 ▲ Increasing +0.05 Cr
Molbio Diagnostics Limited Aug 2026 ▲ New position +0.04 Cr
Sun Pharmaceutical Industries Limited Aug 2026 ▼ Reducing -0.03 Cr
Cipla Limited Aug 2026 ▲ Increasing +0.03 Cr
Anthem Biosciences Limited Aug 2026 ▲ Increasing +0.02 Cr
Mankind Pharma Limited Aug 2026 ▲ Increasing +0.02 Cr
Thyrocare Technologies Limited Aug 2026 ▼ Reducing -0.02 Cr
Emcure Pharmaceuticals Limited Aug 2026 ▼ Reducing -0.01 Cr
GlaxoSmithKline Pharmaceuticals Limited Aug 2026 ▲ Increasing +0.01 Cr
Akums Drugs and Pharmaceuticals Limited Aug 2026 ▼ Reducing -53,611
Divi's Laboratories Limited Aug 2026 ▼ Reducing -50,000
Abbott India Limited Aug 2026 ▲ Increasing +3,324
Piramal Pharma Limited Jul 2026 ▲ Increasing +0.44 Cr
Biocon Limited Jul 2026 ▲ Increasing +0.05 Cr
Dr. Reddy's Laboratories Limited Jul 2026 ▼ Reducing -0.04 Cr
Thyrocare Technologies Limited Jul 2026 ▼ Reducing -0.04 Cr
Vijaya Diagnostic Centre Limited Jul 2026 ▼ Reducing -0.02 Cr
Aurobindo Pharma Limited Jul 2026 ▼ Reducing -0.01 Cr
Akums Drugs and Pharmaceuticals Limited Jul 2026 ▼ Reducing -84,034
Sanofi India Limited Jul 2026 ▲ Increasing +70,000
Mankind Pharma Limited Jul 2026 ▼ Reducing -26,766
Dr. Lal Path Labs Ltd. Jul 2026 ▼ Reducing -17,646
GlaxoSmithKline Pharmaceuticals Limited Jul 2026 ▲ Increasing +15,615
Abbott India Limited Jul 2026 ▲ Increasing +463
Piramal Pharma Limited Jun 2026 ▲ New position +0.55 Cr
Aurobindo Pharma Limited Jun 2026 ▼ Reducing -0.04 Cr
Vijaya Diagnostic Centre Limited Jun 2026 ▼ Reducing -0.02 Cr
Fortis Healthcare Limited Jun 2026 ▲ Increasing +0.02 Cr
Sun Pharmaceutical Industries Limited Jun 2026 ▼ Reducing -0.02 Cr
Ajanta Pharma Limited Jun 2026 ▼ Reducing -32,405
Akums Drugs and Pharmaceuticals Limited Jun 2026 ▼ Reducing -25,947
Syngene International Limited May 2026 ▲ Increasing +0.09 Cr
Vijaya Diagnostic Centre Limited May 2026 ▼ Reducing -0.04 Cr
Mankind Pharma Limited May 2026 ▲ Increasing +0.03 Cr
Cipla Limited May 2026 ▲ Increasing +0.03 Cr
Aurobindo Pharma Limited May 2026 ▼ Reducing -0.03 Cr
Dr. Lal Path Labs Ltd. May 2026 ▼ Reducing -0.02 Cr
Divi's Laboratories Limited May 2026 ▼ Reducing -0.01 Cr
Lupin Limited May 2026 ▼ Reducing -0.01 Cr
Medplus Health Services Limited May 2026 ▼ Reducing -82,048
Thyrocare Technologies Limited May 2026 ▼ Reducing -33,271
Abbott India Limited May 2026 ▲ Increasing +152
J.B. Chemicals & Pharmaceuticals Lt Apr 2026 ▼ Complete exit -0.08 Cr
Dr. Reddy's Laboratories Limited Apr 2026 ▲ Increasing +0.07 Cr
Syngene International Limited Apr 2026 ▲ Increasing +0.07 Cr
Vijaya Diagnostic Centre Limited Apr 2026 ▼ Reducing -0.04 Cr
Sun Pharmaceutical Industries Limited Apr 2026 ▲ Increasing +0.01 Cr
Thyrocare Technologies Limited Apr 2026 ▲ Increasing +8,060
Biocon Limited Mar 2026 ▼ Reducing -0.07 Cr
Max Healthcare Institute Limited Feb 2026 ▲ Increasing +0.14 Cr
Mankind Pharma Limited Feb 2026 ▲ Increasing +0.02 Cr
J.B. Chemicals & Pharmaceuticals Lt Feb 2026 ▼ Reducing -0.02 Cr
Dr. Reddy's Laboratories Limited Feb 2026 ▼ Reducing -0.02 Cr
Apollo Hospitals Enterprise Limited Feb 2026 ▼ Reducing -0.01 Cr
Narayana Hrudayalaya Ltd. Feb 2026 ▼ Reducing -0.01 Cr
Ajanta Pharma Limited Feb 2026 ▼ Reducing -13,000
Syngene International Limited Jan 2026 ▲ Increasing +0.05 Cr
Orchid Pharma Limited Jan 2026 ▼ Complete exit -0.05 Cr
Max Healthcare Institute Limited Jan 2026 ▲ Increasing +0.04 Cr
IPCA Laboratories Limited Jan 2026 ▲ Increasing +0.02 Cr
Mankind Pharma Limited Jan 2026 ▲ Increasing +0.01 Cr
Biocon Limited Dec 2025 ▼ Reducing -0.20 Cr
Gland Pharma Limited Dec 2025 ▼ Reducing -0.05 Cr
Lupin Limited Dec 2025 ▼ Reducing -0.02 Cr
Syngene International Limited Dec 2025 ▲ Increasing +0.01 Cr
IPCA Laboratories Limited Dec 2025 ▲ Increasing +70,000
Divi's Laboratories Limited Dec 2025 ▼ Reducing -50,000
Emcure Pharmaceuticals Limited Dec 2025 ▲ Increasing +6,078
Abbott India Limited Dec 2025 ▲ Increasing +5,510
Biocon Limited Nov 2025 ▼ Reducing -0.05 Cr
Emcure Pharmaceuticals Limited Nov 2025 ▲ Increasing +0.03 Cr
Thyrocare Technologies Limited Nov 2025 ▼ Reducing -0.03 Cr
IPCA Laboratories Limited Nov 2025 ▲ Increasing +0.01 Cr
Divi's Laboratories Limited Nov 2025 ▼ Reducing -99,277
Orchid Pharma Limited Nov 2025 ▼ Reducing -35,166
Max Healthcare Institute Limited Oct 2025 ▲ New position +0.09 Cr
Torrent Pharmaceuticals Limited Oct 2025 ▼ Complete exit -0.03 Cr
Zydus Lifesciences Limited Oct 2025 ▼ Complete exit -0.02 Cr
IPCA Laboratories Limited Oct 2025 ▲ Increasing +0.02 Cr
Narayana Hrudayalaya Ltd. Oct 2025 ▼ Reducing -0.01 Cr
Thyrocare Technologies Limited Oct 2025 ▼ Reducing -24,136
Zydus Lifesciences Limited Sep 2025 ▼ Reducing -0.18 Cr
Biocon Limited Sep 2025 ▲ Increasing +0.05 Cr
Lupin Limited Sep 2025 ▲ Increasing +0.04 Cr
Cipla Limited Sep 2025 ▲ Increasing +0.03 Cr
Thyrocare Technologies Limited Sep 2025 ▼ Reducing -0.02 Cr
IPCA Laboratories Limited Sep 2025 ▲ Increasing +34,608
Biocon Limited Aug 2025 ▲ Increasing +0.03 Cr
Dr. Lal Path Labs Ltd. Aug 2025 ▼ Reducing -50,000
Anthem Biosciences Limited Jul 2025 ▲ New position +0.11 Cr
Suraksha Diagnostic Limited Jul 2025 ▲ Increasing +0.06 Cr
Akums Drugs and Pharmaceuticals Limited Jul 2025 ▲ Increasing +0.06 Cr
Dr. Reddy's Laboratories Limited Jul 2025 ▲ Increasing +0.05 Cr
Narayana Hrudayalaya Ltd. Jul 2025 ▼ Reducing -0.04 Cr
Gland Pharma Limited Jul 2025 ▼ Reducing -0.02 Cr
Divi's Laboratories Limited Jul 2025 ▼ Reducing -70,000
Dr. Lal Path Labs Ltd. Jul 2025 ▼ Reducing -50,000

Changes compare consecutive month-end disclosures for this portfolio only.